Which of the following interventions is specifically for geographic atrophy in AMD?

The intervention specifically indicated for geographic atrophy in age-related macular degeneration (AMD) is Intravitreal Pegcetacoplan. This treatment is a complement C3 inhibitor that works by targeting the underlying pathological processes of geographic atrophy, which is a form of advanced AMD characterized by the progressive loss of retinal pigment epithelium and photoreceptors. By inhibiting the complement pathway, Pegcetacoplan aims to slow down the progression of atrophy, thereby preserving vision in patients affected by this condition.

The other options, such as AREDS2 supplements, while beneficial for overall retinal health and in slowing the progression of AMD, do not specifically target geographic atrophy nor have they been shown to reverse or specifically treat this condition. Laser photocoagulation is typically reserved for exudative AMD with choroidal neovascularization and is not effective for geographic atrophy. Oral steroids may be used for inflammatory conditions but do not address the specific pathology of geographic atrophy in AMD. Thus, Intravitreal Pegcetacoplan is the only treatment among the choices that is specifically designed to manage geographic atrophy.